MedPath

Single-center, unblinded, randomized comparison study between new cardiopulmonary bypass circuit "Oxia N" and existing circuit.

Not Applicable
Conditions
aortic arch aneurysm
Registration Number
JPRN-UMIN000035888
Lead Sponsor
Keio University School of Medicine, Department of Cardiovscular Surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who are judged that clinical evaluation can not be performed properly, depending on the judgment of the attending surgeon. (renal dysfunction, liver dysfunction, diabetes, anticoagulation disorder, malignant tumor, autoimmune disease etc.)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Protein in blood, inflammatory marker, coagulation marker are measured at the following 6 points. That is, before the start of extracorporeal circulation, immediately after the start of extracorporeal circulation, 60 minutes after extracorporeal circulation, at the end of extracorporeal circulation, 120 minutes after extracorporeal circulation, after the first sickness day.
Secondary Outcome Measures
NameTimeMethod
SEM observation Regarding products such as artificial lung, centrifugal pump etc. after extracorporeal circulation
© Copyright 2025. All Rights Reserved by MedPath